Regonol Injection, Solution
Product Images NDC 0781-3040

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Regonol (NDC 0781-3040). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Regonol 01

Chemical structure diagram of pyridostigmine bromide, the active ingredient in Regonol injection solution, 5 mg/mL by Sandoz Inc. The structure shows a quaternary ammonium pyridine ring linked to a carbamate group and a bromide ion.*

FDA Label Image

Regonol 02

Regonol (Pyridostigmine Bromide Injection, USP) 10 mg/2 mL (5 mg/mL) sterile injection solution for intravenous use. The label indicates 10 single-dose ampules of 2 mL each. Distributed by Sandoz Inc. The packaging warns that the product contains benzyl alcohol and is not for use in neonates.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.